Literature DB >> 26977548

Anterior Cruciate Ligament Injuries in Females: Risk Factors, Prevention, and Outcome.

Stephen Gould, Jessica Hooper, Eric Strauss.   

Abstract

Anterior cruciate ligament (ACL) injuries are common among all participants in sports, occurring in approximately 1 in 3,000 individuals yearly in the USA. Epidemiological studies of ACL injuries have demonstrated that females are at higher risk for injury than males. When compared to male athletes participating in the same sports, the risk of ACL injury is two to eight times greater in females.1-3 A significant research effort has been directed at identifying risk factors that may predispose females to ACL injury. Female athletes likely have an increased incidence of ACL injury due to anatomic, hormonal, biomechanical, and neuromuscular differences between the sexes. Extrinsic factors may also play a role. As the number of girls and women participating in athletics continues to increase, understanding risk factors and developing prevention strategies will have profound physical, psychological, and financial implications for female athletes and the medical system.

Entities:  

Mesh:

Year:  2016        PMID: 26977548

Source DB:  PubMed          Journal:  Bull Hosp Jt Dis (2013)        ISSN: 2328-4633


  3 in total

1.  Patterns of presentation and early treatment outcomes of anterior cruciate ligament injury at the National Orthopaedic Hospital, Lagos, Nigeria: a retrospective cross-sectional study.

Authors:  Oladimeji Ranti Babalola; Wahab Egberongbe; Kehinde Sunday Oluwadiya
Journal:  Pan Afr Med J       Date:  2022-04-20

2.  Do Relaxin Levels Impact Hip Injury Incidence in Women? A Scoping Review.

Authors:  Emily A Parker; Alex M Meyer; Jessica E Goetz; Michael C Willey; Robert W Westermann
Journal:  Front Endocrinol (Lausanne)       Date:  2022-02-04       Impact factor: 5.555

3.  Association between polymorphism rs12722 in COL5A1 and musculoskeletal soft tissue injuries: a systematic review and meta-analysis.

Authors:  Zheng-Tao Lv; Shu-Tao Gao; Peng Cheng; Shuang Liang; Si-Yi Yu; Qing Yang; An-Min Chen
Journal:  Oncotarget       Date:  2017-12-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.